Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589810 · ClinicalTrials.gov registry record
Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 761
- Enrollment target
NCT00589810: Completed study, sponsored by The Cleveland Clinic.
NCT00589810 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 761 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00589810 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 761 participants
- Enrollment target
Study Summary
In this replication study at the Cleveland Clinic, we seek to collaborate to validate findings of the CardioGene Study in an independent cohort of patients who have undergone bare metallic stenting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 761 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-11 |
What the finished NCT00589810 record still lists
NCT00589810 is an observational study that tracks outcomes without assigning an intervention. The registered 761 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00589810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00589810 about?
NCT00589810 is a clinical study titled "Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal". In this replication study at the Cleveland Clinic, we seek to collaborate to validate findings of the CardioGene Study in an independent cohort of patients who have undergone bare metallic stenting.
What is the current status of trial NCT00589810?
This trial is currently completed. The enrollment target is 761 participants. The study started on 2007-08. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT00589810?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06419374 · 762 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- NCT02089607 · 760 participants · NA
CAAAs, TAAAs, Aortic Arch Aneurysms or Dissections With Fenestrated/Branched Stent Graft
- NCT04073706 · 760 participants · Phase 3
Sentinel Node Biopsy in Endometrial Cancer
- NCT05129228 · 760 participants · NA
Optical Coherence Tomography of the Saphenous Vein Graft
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia